Creative Planning Supernus Pharmaceuticals, Inc. Transaction History

Creative Planning

$103 Billion
Q4 2024

A detailed history of Creative Planning transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Creative Planning holds 7,202 shares of SUPN stock, worth $228,735. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,202

Holding current value

$228,735

% of portfolio

0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$31.89 - $37.83 $229,671 - $272,451	7,202 New	7,202 $260,000
Q1 2024 May 10, 2024	BUY	$27.11 - $35.17 $180,877 - $234,654	6,672 New	6,672 $227,000
Q3 2023 Nov 16, 2023	BUY	$27.57 - $32.91 $3,528 - $4,212	128 New	128 $3,000
Q3 2019 Nov 01, 2019	SELL	$25.47 - $33.37 $438,797 - $574,898	-17,228 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$29.96 - $38.87 $113,907 - $147,783	3,802 Added 28.32%	17,228 $570,000
Q1 2019 Apr 24, 2019	BUY	$32.77 - $41.99 $150,807 - $193,237	4,602 Added 52.15%	13,426 $470,000
Q4 2018 Feb 01, 2019	SELL	$30.84 - $49.51 $365,885 - $587,386	-11,864 Reduced 57.35%	8,824 $293,000
Q3 2018 Oct 25, 2018	SELL	$42.7 - $56.55 $1,323 - $1,753	-31 Reduced 0.15%	20,688 $1.04 Million
Q2 2018 Jul 20, 2018	BUY	$44.1 - $59.85 $194,701 - $264,237	4,415 Added 27.08%	20,719 $1.24 Million
Q1 2018 Apr 18, 2018	SELL	$37.15 - $46.9 $214,504 - $270,800	-5,774 Reduced 26.15%	16,304 $747,000
Q4 2017 Jan 17, 2018	SELL	$36.4 - $42.6 $107,598 - $125,925	-2,956 Reduced 11.81%	22,078 $880,000
Q3 2017 Oct 17, 2017	BUY	$36.75 - $49.65 $919,999 - $1.24 Million	25,034	25,034 $1 Million

Others Institutions Holding SUPN

# of Institutions

303

Shares Held

60.6M

Call Options Held

22.3K

Put Options Held

Black Rock Inc. New York, NY

10.4M
Shares

$330 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

6.15M
Shares

$195 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

4.84M
Shares

$154 Million
2.47% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.88M
Shares

$91.4 Million
0.03% of portfolio
Macquarie Group LTD Australia, C3

2.63M
Shares

$83.5 Million
0.11% of portfolio

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.7B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account